Building Your Care Team and Daily Management
At a Glance
Children with DEND syndrome need coordinated diabetes, neurology, genetics, and therapy care, plus glucose, feeding, and seizure planning. Families should keep records, follow a written sick-day plan, and know when severe low blood sugar, seizures, or dehydration require emergency help.
Managing DEND or iDEND syndrome is a long-term journey that requires a dedicated team and careful daily routines. Because the condition is so rare, your role as an important advocate and partner is vital while making clear that care coordination is a responsibility of the clinical team as well. By building a strong team and keeping detailed records, you ensure that every specialist has the information they need to provide the best care [1][2].
Building Your Expert Team
Because DEND affects both the pancreas and the brain, your child needs a multidisciplinary team—a group of specialists who work together [1]. This team should include:
- Pediatric Endocrinologist: The lead for managing diabetes and the transition to sulfonylureas [2].
- Pediatric Neurologist: To monitor brain development, manage epilepsy, and track muscle tone [3].
- Medical Geneticist: To interpret the genetic report and provide counseling for your family [4].
- Therapy Specialists: Physical (PT), Occupational (OT), and Speech-Language (SLP) therapists to support motor skills and developmental milestones [1][3].
- Diabetes Educator & Nutritionist: To help you master the technology and ensure your child gets the nutrition they need for growth [2].
Preparing for Your First Appointment
When you meet a new specialist, having the right “artifacts” (physical records) can save time and prevent errors. Bring a folder containing:
- The Molecular Genetic Test Report: The single most important document for determining treatment [3].
- Glucose Logs: Printed reports from your Continuous Glucose Monitor (CGM) or a handwritten log of finger-stick readings [5].
- Medication List: The exact doses and times for all medications, including insulin and sulfonylureas.
- Growth Charts: Records of your child’s weight and height over time [6].
Daily Management and Safety
Daily life with DEND involves balancing medication, feeding, and monitoring. Most families use a CGM to watch blood sugar trends, but it is important to remember that CGM sensors can be less accurate during rapid changes or very low readings in infants [7]. Always treat a symptomatic or clearly low reading immediately, even if waiting for a finger-stick confirmation, unless the treating team has given a different plan [7].
Feeding is Safety
Sulfonylureas work by helping the pancreas release insulin. If your child does not eat enough, or if they vomit their meal, the medication may still cause their body to release insulin, leading to low blood sugar [8]. Never skip a feeding while on high-dose sulfonylureas without following your doctor’s “sick day” plan [9]. Do not force feeds or oral medication into a vomiting, lethargic, or unsafe-to-swallow child. Contact the diabetes team for urgent clinical advice and follow written instructions for glucose, ketones, and medication.
Red Flags: When to Seek Emergency Care
While side effects from sulfonylureas are often mild (such as temporary stomach upset), you must be able to recognize critical “red flags” that require immediate medical attention [6][10].
| Sign | What it Looks Like | Action |
|---|---|---|
| Severe Hypoglycemia | Extreme sleepiness, inability to wake up, shaking, sweating, or a seizure when blood sugar is low [10][11]. | DO NOT give anything by mouth to an unconscious or seizing child (aspiration risk). If awake and swallowing, give fast-acting carbs. If unconscious/seizing, administer prescribed glucagon and call 911 immediately. |
| Uncontrolled Seizures | A seizure lasting 5 minutes or more, repeated seizures without recovery, or breathing difficulty [12][13]. | Call 911 (emergency services). Use rescue medication only as prescribed by your neurologist. |
| Diabetic Ketoacidosis (DKA) Signs | Vomiting with deep/rapid breathing, altered consciousness, severe dehydration, or significant ketones [14][15]. | Call 911 or go to the nearest Emergency Room immediately. |
Consistent monitoring and a clear communication channel with your team are your best defenses against these emergencies [1]. Many families find it helpful to keep a “Go Bag” packed with emergency glucose, a glucometer, and a copy of their child’s emergency medical plan.
Common questions in this guide
What specialists should be on my child’s DEND syndrome care team?
What records should I bring to a DEND syndrome appointment?
What should I do if my child vomits or will not eat after taking a sulfonylurea?
How do I recognize severe low blood sugar in a child with DEND syndrome?
When does a seizure or diabetes symptom require emergency care?
How can I prepare other caregivers and school staff for DEND syndrome emergencies?
Get notified when new evidence is published on DEND syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Neonatal Diabetes Mellitus.
Beltrand J, Busiah K, Vaivre-Douret L, et al.
Frontiers in pediatrics 2020; (8()):540718 doi:10.3389/fped.2020.540718.
PMID: 33102403 - 2
Psychiatric morbidity in children with KCNJ11 neonatal diabetes.
Bowman P, Broadbridge E, Knight BA, et al.
Diabetic medicine : a journal of the British Diabetic Association 2016; (33(10)):1387-91 doi:10.1111/dme.13135.
PMID: 27086753 - 3
Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls.
Carmody D, Pastore AN, Landmeier KA, et al.
Diabetic medicine : a journal of the British Diabetic Association 2016; (33(10)):1380-6 doi:10.1111/dme.13159.
PMID: 27223594 - 4
Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.
Lemelman MB, Letourneau L, Greeley SAW
Clinics in perinatology 2018; (45(1)):41-59 doi:10.1016/j.clp.2017.10.006.
PMID: 29406006 - 5
Use of a long-term continuous glucose monitor for predicting sulfonylurea dose in patients with neonatal diabetes mellitus: a case series.
Tagawa K, Matsui K, Tsukamura A, et al.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2024; (33(3)):131-138 doi:10.1297/cpe.2023-0062.
PMID: 38993723 - 6
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
Bowman P, Sulen Å, Barbetti F, et al.
The lancet. Diabetes & endocrinology 2018; (6(8)):637-646 doi:10.1016/S2213-8587(18)30106-2.
PMID: 29880308 - 7
Continuous glucose monitoring in neonates: a review.
McKinlay CJD, Chase JG, Dickson J, et al.
Maternal health, neonatology and perinatology 2017; (3()):18 doi:10.1186/s40748-017-0055-z.
PMID: 29051825 - 8
Safety and Effectiveness of Oral Glyburide Suspension in Neonatal Diabetes Mellitus: French Retrospective Cohort Study.
Ben Rhaiem I, Beltrand J, Vermillac G, et al.
Journal of the Endocrine Society 2025; (9(7)):bvaf083 doi:10.1210/jendso/bvaf083.
PMID: 40469835 - 9
Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes.
Beltrand J, Baptiste A, Busiah K, et al.
Pediatric diabetes 2019; (20(3)):246-254 doi:10.1111/pedi.12823.
PMID: 30684309 - 10
Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures.
Lanning MS, Carmody D, Szczerbiński Ł, et al.
Pediatric diabetes 2018; (19(3)):393-397 doi:10.1111/pedi.12599.
PMID: 29205704 - 11
Prehospital identification of hypoglycemia-induced seizure using a smartphone-linked continuous glucose monitoring application.
Harada K, Okazaki Y, Ichiba T
The American journal of emergency medicine 2026; (107()):13-15 doi:10.1016/j.ajem.2026.05.021.
PMID: 42119276 - 12
Long-Term Seizure and Neurodevelopmental Outcomes of Three Children with Developmental Delay, Epilepsy, and Neonatal Diabetes (DEND) Syndrome after Early Initiation of Sulphonylurea.
Baby N, Vinayan KP, Pavithran P, et al.
Annals of Indian Academy of Neurology 2025; (28(5)):725-728 doi:10.4103/aian.aian_1097_24.
PMID: 41099379 - 13
Hyperglycaemia-related complications at the time of diagnosis can cause permanent neurological disability in children with neonatal diabetes.
Day JO, Flanagan SE, Shepherd MH, et al.
Diabetic medicine : a journal of the British Diabetic Association 2017; (34(7)):1000-1004 doi:10.1111/dme.13328.
PMID: 28173619 - 14
De Novo KCNJ11 Mutation in an Infant With Neonatal Diabetes Mellitus Presenting as Diabetic Ketoacidosis: A Case Report and Literature Review.
Mujahed RH, Shawabka AM, Daghlis NM, et al.
Journal of investigative medicine high impact case reports 2025; (13()):23247096251368092 doi:10.1177/23247096251368092.
PMID: 40842261 - 15
Not All Diabetic Ketoacidosis in Infant Is Type 1: A Case Report Permanent Neonatal Diabetes.
Al Homyani DK, Al Homaiani L
AACE clinical case reports 2024; (10(1)):7-9 doi:10.1016/j.aace.2023.10.004.
PMID: 38303767
This page is for informational purposes only and does not constitute medical advice. Your child’s endocrinology and neurology teams should provide individualized instructions for medicines, sick-day care, glucose thresholds, seizures, and emergencies.